Impact of COVID-19 on HV trials [Study Per­for­mance]

posted by Ohlbe – France, 2020-04-20 12:11 (1439 d 05:50 ago) – Posting: # 21337
Views: 2,620

Dear Silvia,

❝ Could the Clinical step of a BE study (screening, recruiting, administration of formulations and blood samples extractions) be carried out maintaining the HV at their own homes (always with a nurse at all times and a medical doctor visiting all the volunteers, etc etc)?


Besides what you already mention (certification of clinical centres), I see several hurdles and I don't think what you propose would be feasible/acceptable for ethics committees and authorities:
Sorry but I think all we can do is be patient...

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,636 registered users;
99 visitors (0 registered, 99 guests [including 14 identified bots]).
Forum time: 17:02 CET (Europe/Vienna)

With four parameters I can fit an elephant,
and with five I can make him wiggle his trunk.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5